Thomas J. Polascik, MD

Articles by Thomas J. Polascik, MD

Prostate Cancer Focal Therapy Has Made Great Strides and the Future Remains Bright

May 14th 2021

Thomas J. Polascik, MD, reflects on a manuscript written by his colleagues regarding the use of focal therapy to treat localized prostate cancer.

Low-Risk and Very-Low-Risk Prostate Cancer: Is There a Role for Focal Therapy in the Era of Active Surveillance? Yes, the Two Approaches Complement Each Other

ByLaurence Klotz, MD, FRCSC, CM,Thomas J. Polascik, MD

November 15th 2014

Investigators and physicians caring for the spectrum of prostate cancer should have a targeted treatment option available for patients who would benefit by it.

Latest Updated Articles

Prostate Cancer Focal Therapy Has Made Great Strides and the Future Remains Bright
Published: May 14th 2021 | Updated:
Low-Risk and Very-Low-Risk Prostate Cancer: Is There a Role for Focal Therapy in the Era of Active Surveillance? Yes, the Two Approaches Complement Each Other
Published: November 15th 2014 | Updated:

Thomas J. Polascik, MD

Articles by Thomas J. Polascik, MD

Prostate Cancer Focal Therapy Has Made Great Strides and the Future Remains Bright

Low-Risk and Very-Low-Risk Prostate Cancer: Is There a Role for Focal Therapy in the Era of Active Surveillance? Yes, the Two Approaches Complement Each Other

Latest Updated Articles

Trending on CancerNetwork

Anito-Cel May Have Efficient Mechanism in R/R Multiple Myeloma Treatment

Axi-cel Produces Enduring Real-World Responses in R/R Follicular Lymphoma

Frontline Giredestrant Displays IDFS Improvement vs SOC ET in ER+/HER2– BC

Durvalumab Plus Platinum-Etoposide Displays Feasibility in ES-SCLC

Axi-Cel Yields Boosted Survival in Patients With High-Risk LBCL and 6-Month CR